Sanofi stock pre-market at EUR 70.41: minus 0.17 percent
Published on 10/06/2026 at 08:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanofi stock was at EUR 70.41 pre-market at 8:05 a.m. CEST on October 6, 2026, according to Lang & Schwarz. The price was down 0.17 percent versus the Lang & Schwarz prior close of EUR 70.53 on October 5, 2026.
Sanofi stock before the Xetra open
Lang & Schwarz showed a bid of EUR 70.34 and an ask of EUR 70.48. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Sanofi stock.
Expanded antibody alliance
Sanofi and Regeneron announced on October 1, 2026, that they had expanded their long-standing antibody collaboration. The agreement covers four new long-acting antibodies targeting interleukin-13, an IL-4xIL-13 bispecific, interleukin-4 and interleukin-4 receptor alpha, according to the Regeneron release.
Under the agreement, Sanofi will pay Regeneron USD 1 billion upfront, with up to an additional USD 7 billion in development, regulatory and commercial milestone payments. The companies will share development and commercialization costs and split potential future profits equally worldwide; Regeneron will lead research and development, while Sanofi will lead global commercial efforts, the Sanofi investor-relations page reported.
